Lloyd Price

NOVEMBER 8, 2024

Exec Summary: The HealthTech sector is poised for significant M&A activity in 2025, driven by several key trends: Digital Health Solutions: The increasing demand for digital health solutions to improve healthcare accessibility and efficiency will drive acquisitions of innovative startups and established players in this space.

Digital Health 52

Digital Health healthcare technology Pharmaceuticals Telehealth 52

Healthcare IT News - Telehealth

MAY 29, 2020

“These technologies can also be leveraged by pharmaceutical companies to monitor the results of the drugs developed by them," said Ashish Kaul, technical insights senior research analyst at Frost & Sullivan. THE LARGER CONTEXT. She cites examples such as Binah.ai

Mental health 179

Mental health Drug Development Pharmaceuticals Telehealth 179

Lloyd Price

NOVEMBER 16, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

Drug Development 70

Drug Development healthcare technology Leadership Life Science 70

Digital Health Global

MARCH 29, 2023

With ResponderID, we sought to disrupt the historical linear progression of drug discovery and development, rather aiming to close the loop between drug development, patient care and new drug discovery,” said Rafael Rosengarten, Ph.D., co-founder and CEO of Genialis. “We

Drug Development 128

Drug Development Pharmaceuticals Life Science Digital Health 128

Lloyd Price

OCTOBER 14, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

Leadership 56

Leadership healthcare technology Digital Health Mental health 56

Digital Health Global

JANUARY 9, 2024

The investment adds to a growing list of prominent digital health investors in Europe and the United States, including Nina Capital and Young Sohn, a co-founder of Veeva Systems. The funding speaks to the global nature of pre-approval access and its increasing importance in the drug development process. “

Pharmaceuticals 88

Pharmaceuticals Drug Development Digital Health Health Technology 88

Digital Health Global

MARCH 26, 2024

BASEL, Switzerland–(BUSINESS WIRE)–Indivi, a leading MedTech company headquartered in Basel, Switzerland, has entered into an agreement with Biogen to advance digital health technology and develop digital biomarkers for Parkinson’s disease.

Health Technology 88

Health Technology Digital Health BioTech Drug Development 88

Digital Health Global

APRIL 5, 2024

DUBLIN–(BUSINESS WIRE)–The “Growth Opportunities in Drug Discovery and Early Development Outsourcing Services” report has been added to ResearchAndMarkets.com’s offering. hike over 2022, with more than 6,100 molecules in active development.

Drug Development 88

Drug Development Pharmaceuticals Digital Health Health Technology 88

Healthcare IT Today

JANUARY 7, 2025

As these implementations take hold, the emphasis will be on demonstrating measurable return on investment (ROI), with AI driving down administrative burdens, accelerating drug development, and significantly improving operational efficiency. What’s most exciting to me is AI’s potential impact on personalized medicine.

Health IT 93

Health IT Life Science Drug Development Pharmaceuticals 93

Digital Health Global

SEPTEMBER 28, 2023

The new seed funding activity will therefore pave the way for the next generation of treatments and digital health, providing healthcare professionals with better tools to improve experiences and outcomes for patients. Since 2017 Debiopharm has invested in 15 AI and digital health companies, typically leading the investment rounds.

Drug Development 88

Drug Development Pharmaceuticals Digital Health Life Science 88

Digital Health Global

AUGUST 30, 2023

QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. This decline is happening at a time when the need for efficient drug development has never been greater. This happens because there are major gaps in the research needed to support clinical trials.

BioTech 88

BioTech Drug Development Life Science Pharmaceuticals 88

Digital Health Global

AUGUST 22, 2024

Spellman and Wortel are the most recent additions to Catawba Research’s team of scientific and regulatory advisors who support sponsors across a multitude of therapeutic areas and provide clinical development and regulatory strategy across North America, Europe and Asia.

Leadership 88

Leadership Pharmaceuticals Drug Development Digital Health 88

Digital Health Global

JUNE 2, 2024

1 The collaboration between Massive Bio and Mika Health will also benefit the research both companies are performing with pharmaceutical companies and patient advocacy groups, by providing real-world data and insights into patient experiences and treatment outcomes.

Drug Development 88

Drug Development Pharmaceuticals Mental health Patient Experience 88

Lloyd Price

JANUARY 20, 2025

In the context of healthtech and digital health, it means a company initially targets consumers (B2C), builds a strong user base, and then leverages this consumer adoption to attract businesses (B2B), such as insurers, employers, or healthcare providers. Exec Summary: B2C2B stands for Business-to-Consumer-to-Business.

Mental health 60

Mental health healthcare technology Telehealth Digital Health 60

Digital Health Global

JANUARY 8, 2024

Top-10 global pharmaceutical companies are already benefiting from Medable’s novel technology, shaving weeks off build times. Its digital clinical trials platform enhances speed, scale, and patient access in clinical research, accelerating medicines for thousands of conditions without treatment or cure.

Life Science 88

Life Science Drug Development Pharmaceuticals HIPAA 88

Society for Participatory Medicine

JANUARY 27, 2022

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. Market forces drove acceleration in digital health, specifically telemedicine, which were sorely needed for several years.

BioTech 97

BioTech Life Science Drug Development Patient Experience 97

Digital Health Global

APRIL 16, 2024

The Phase IV trial, funded by a top-10 global pharmaceutical company, had a narrow recruitment window to enroll patients suffering from Anemia in End Stage Kidney Disease (ESKD) across more than 40 dialysis centers, involving 476 site users. .–(BUSINESS WIRE)– Medable Inc. , Renal Care ’s (USRC) investigator-initiated trial.

Drug Development 88

Drug Development Pharmaceuticals Health science Digital Health 88

Digital Health Global

JUNE 20, 2023

million from Capital Grand Est and MACSF, as well as business angels, to accelerate its development in Europe and the United States. STRASBOURG, France–(BUSINESS WIRE)– BrainTale, a French medtech deciphering white matter to enable better brain care, announces it has gathered € 4.5 Today, the company has gathered €4.5

Life Science 88

Life Science Drug Development BioTech Pharmaceuticals 88

Xealth

JUNE 27, 2023

David Slifka, Vice President, Commercial Enablement The digital health ecosystem is a complex place. Confusion abounds among healthcare providers regarding digital therapeutics (DTx) terminology and classifications, and understandably so. DTx fall within the digital medicine subset within the larger digital health ecosystem.

Digital Health 52

Digital Health Drug Development Pharmaceuticals Nursing 52

Digital Health Today

SEPTEMBER 6, 2019

Our guest is Francesca Wuttke, PhD, the Chief Digital Officer of Almirall. Almirall is an international pharmaceutical company founded in 1943 and based in Barcelona – which is where Francesca is based. Francesca is responsible for developing and executing an end-to-end company-wide digital transformation.

Digital Health 66

Digital Health Drug Development Pharmaceuticals 66

Digital Health Global

NOVEMBER 2, 2023

Wearable monitoring devices, genomics, and AI play vital roles in this transformation, enabling personalized interventions and collective health data sharing for research. Drug development The traditional drug discovery process is characterized by its protracted timeline, high costs, and significant attrition rates among drug candidates.

Drug Development 88

Drug Development Pharmaceuticals Telehealth Public Health 88

Digital Health Global

SEPTEMBER 27, 2023

About Automera Automera is an early-stage company focused on the development of a novel therapeutic approach via autophagy-based targeted protein degradation. About ClavystBio ClavystBio’s mission is to accelerate the commercialization of life science breakthroughs into health impact.

Life Science 88

Life Science Drug Development HC BioTech 88

Digital Health Today

AUGUST 7, 2019

Digital Therapeutics (DTx) have been under the spotlight this past year. They have the potential to become a game changer in healthcare for patients, healthcare professionals, pharmaceuticals and insurance companies. The Digital Therapeutics Alliance developed a definition to differentiate DTx solutions from health and wellness apps.

Pharmaceuticals 70

Pharmaceuticals Digital Health Drug Development Primary Care 70

Lloyd Price

DECEMBER 11, 2023

The WHO and the India G20 presidency emphasised its importance by launching ‘The Global Initiative of Digital Health’ (GIDH) in August, proclaiming: “Digital health is a proven accelerator to advance health outcomes and achieve Universal Health Coverage and health-related Sustainable Development Goals.”

Pharmaceuticals 64

Pharmaceuticals Digital Health Drug Development Life Science 64

Digital Health Global

MARCH 16, 2023

About Wellington Partners Wellington Partners is a leading European venture capital firm investing in the most promising early- and growth stage life science companies in the fields of biotechnology, therapeutics, medical technology, diagnostics and digital health. With funds totaling more than €1.2 Forbion manages well over EUR 2.3

Life Science 88

Life Science Pharmaceuticals BioTech Drug Development 88

Lloyd Price

NOVEMBER 21, 2023

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Email lloyd@nelsonadvisors.co.uk Subscribe Today! Buy, build or partner?

Drug Development 70

Drug Development Health science healthcare technology Leadership 70

Healthcare IT News - Telehealth

MAY 6, 2020

Bardy Diagnostics is a digital health and remote patient monitoring company focused on addressing a long-standing complaint by cardiac electrophysiologists and cardiologists regarding their frequent inability to clearly distinguish the P-wave on ECG strips of existing monitors. And the list will continue to be updated over time.

Connected Health 216

Connected Health Telehealth Pharmaceuticals EHR 216

Lloyd Price

FEBRUARY 18, 2024

Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Pharmaceuticals 64

Pharmaceuticals healthcare technology Digital Health Remote care 64

Lloyd Price

FEBRUARY 18, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! Subscribe Today!

Pharmaceuticals 60

Pharmaceuticals healthcare technology Leadership Drug Development 60

Digital Health Global

JUNE 20, 2023

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Lars Staal Wegner, M.D.

BioTech 88

BioTech Life Science Leadership Drug Development 88

Lloyd Price

MAY 2, 2024

Digital Biology: Tools like BioNeMo utilise AI to analyse vast amounts of biological data, leading to breakthroughs in drug development and understanding of diseases. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

healthcare technology 73

healthcare technology Drug Development Leadership Digital Health 73

Lloyd Price

APRIL 22, 2024

HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Pharma giants acquiring AI drug discovery firms: Pharmaceutical companies are increasingly looking to AI to streamline drug development, leading to potential acquisitions. Subscribe Today!

healthcare technology 60

healthcare technology Leadership Drug Development Digital Health 60

Lloyd Price

SEPTEMBER 29, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

Leadership 64

Leadership Drug Development healthcare technology Digital Health 64

Healthcare IT Today

DECEMBER 31, 2024

Mike King, Senior Director, Product and Strategy at IQVIA Increasing integration between quality, regulatory, and safety teams in pharmaceutical companies as well as the existing strong integrations in these departments in MedTech and IVD organizations.

Interoperability 65

Interoperability Health IT Pharmaceuticals Digital Health 65

Digital Health Global

NOVEMBER 7, 2024

Under this agreement, Aptar Pharma will provide extensive support to CHI, serving as the primary point of contact for customers, preparing for commercial manufacture and integrating Aptar’s comprehensive suite of pharmaceutical services to accelerate the growth of the Quattrii DPI platform.

Healthcare Innovation 88

Healthcare Innovation Pharmaceuticals Drug Development Leadership 88

Digital Health Global

OCTOBER 3, 2023

a trailblazing entity in the realm of digital health technology, proudly announces a pivotal advancement in clinical trial recruitment, fortified by a strategic relationship with Evernorth Health, Inc (ENI).

Drug Development 88

Drug Development Digital Health Pharmaceuticals Health Technology 88